12:00 AM
 | 
Sep 03, 2002
 |  BioCentury  |  Analyst Picks & Changes

Analyst picks & changes

InterMune Inc.

(ITMN), Brisbane, Calif.

Business: Pulmonary, Infectious diseases, Cancer

Morgan Stanley analyst Caroline Copithorne reiterated her "overweight" rating after ITMN last week reported Phase III data for its...

Read the full 141 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury

Article Purchase

$150 USD
More Info >